A simple p53 functional assay for screening cell lines, blood, and tumors.
- 25 April 1995
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 92 (9) , 3963-3967
- https://doi.org/10.1073/pnas.92.9.3963
Abstract
Mutations in the p53 gene are implicated in the pathogenesis of half of all human tumors. We have developed a simple functional assay for p53 mutation in which human p53 expressed in Saccharomyces cerevisiae activates transcription of the ADE2 gene. Consequently, yeast colonies containing wild-type p53 are white and colonies containing mutant p53 are red. Since this assay tests the critical biological function of p53, it can distinguish inactivating mutations from functionally silent mutations. By combining this approach with gap repair techniques in which unpurified p53 reverse transcription-PCR products are cloned by homologous recombination in vivo it is possible to screen large numbers of samples and multiple clones per sample for biologically important mutations. This means that mutations can be detected in tumor specimens contaminated with large amounts of normal tissue. In addition, the assay detects temperature-sensitive mutants, which give pink colonies. We show here that this form of p53 functional assay can be used rapidly to detect germline mutations in blood samples, somatic mutations in tumors, and mutations in cell lines.Keywords
This publication has 26 references indexed in Scilit:
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- Premature translational termination triggers mRNA decappingNature, 1994
- p53: a Glimpse at the Puppet Behind the Shadow PlayScience, 1994
- The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.Genes & Development, 1993
- The rapid detection of unknown mutations in nucleic acidsNature Genetics, 1993
- Screening patients for heterozygous p53 mutations using a functional assay in yeastNature Genetics, 1993
- Detection of Novel Germ-line p53 Mutations in Diverse-Cancer-Prone Families Identifiled by Selecting Patients With Childhood Adrencortical CarcinomaJNCI Journal of the National Cancer Institute, 1992
- Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other NeoplasmsScience, 1990
- The ADE2 gene from Saccharomyces cerevisiae: sequence and new vectorsGene, 1990
- Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53Cell, 1990